Transcranial Electrical Stimulation for Mal de Debarquement Syndrome

March 13, 2023 updated by: University of Minnesota

The goal of this study is to determine whether external neuromodulation using transcranial electrical stimulation (TES) can reduce the perception of self-motion that is experienced by patients with MdDS. Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. A similar form of rocking dizziness can be experienced without a motion trigger in individuals with certain risk factors.

Treatment for MdDS is limited and morbidity is high.The goal of the study is to determine whether TES can suppress the rocking dizziness of MdDS either as a standalone therapy or as an adjunctive therapy to other forms of neuromodulation such as transcranial magnetic stimulation. The investigators will determine the optimal treatment duration and stimulation parameters.

Study Overview

Status

Withdrawn

Detailed Description

Eligible participants who meet study criteria and pass the safety screen will be invited to participate in the study. If TES is used as add-on treatment to repetitive transcranial magnetic stimulation (rTMS), the training for TES application will be done on-site. However, in a portion of the study that does not involve rTMS, remote training will be performed via a webcam provided that a suitable "Study Buddy" is available to assist the participant.

Participants will maintain web-based diaries of their symptoms for up to four weeks prior to treatment with TES. Before the actual treatment sessions are started, the subjects will complete baseline questionnaires online which will be repeated once a week for up to 12 weeks. Over the course of the study, the subjects will also keep a daily log of their sessions such as how many sessions they performed, for how long, and whether they had any side effects with each session.

The studies will include a sham arm, allocated at a ratio of 1:1. On-site studies will involve the application of EEG, MRI, balance, cognitive, and visual/auditory stimulation tests.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Age ≥18 years old
  2. Willing and capable of interacting with the informed consent process
  3. Primary disorder being a persistent perception of motion with no other cause determined after a careful interview.
  4. Able to identity a study buddy and provide contact information

Exclusion Criteria:

  1. Subjects who cannot comply with study conditions.
  2. Active psychiatric condition such as mania or psychosis
  3. Unstable medical condition
  4. Implanted metal in the head or neck (metal or shrapnel, deep brain stimulators, aneurysm clips, cochlear stimulators, retinal implants, etc). Dental fillings are acceptable.
  5. Any active skin disorder that affects skin integrity of the scalp.
  6. Pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Transcranial Electrical Stimulation-Real
The participant will perform real TES. The forms of TES used in this study will include transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or transcranial random noise stimulation (tRNS). Each stimulation session will last for 20-minutes.
A form of external neuromodulation using electrodes on the surface of the head. We will be using the TCT tDCS device (www.trans.cranial.com) or devices constructed by our research group or collaborators.
Other Names:
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Sham Transcranial Stimulation
Sham Comparator: Transcranial Electrical Stimulation-Sham
The participant will perform sham TES for 20-minutes. The form of sham TES will depend on the active arm, e.g. if tACS is on the active arm, then the sham tACS will be a different frequency of stimulation. If tDCS is the active arm, then a short ramp up of tDCS followed by a ramp down (about 60-seconds) will be used as the sham arm.
A form of external neuromodulation using electrodes on the surface of the head. We will be using the TCT tDCS device (www.trans.cranial.com) or devices constructed by our research group or collaborators.
Other Names:
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Sham Transcranial Stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dizziness Handicap Inventory
Time Frame: 10 years
This is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mal de Debarquement Balance Rating Scale
Time Frame: 10 years
This is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function.
10 years
Hospital Anxiety and Depression Scale
Time Frame: 10 years
This is a well validated 42 point self-reported scale of anxiety and dizziness.
10 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF-12
Time Frame: 10 years
Well established Quality of Life Scale
10 years
Motion Sickness Susceptibility Scale
Time Frame: 10 years
Measures motion sickness susceptibility before and after age 12
10 years
Neo-Five Factor Inventory
Time Frame: 10 years
Quantifies the five major personality traits
10 years
Empathy Quotient
Time Frame: 10 years
40 item online or 20 item abbreviated scale to determine strength of empathic traits
10 years
Functional Activities Scale
Time Frame: 10 years
Measures comfort with doing some basic activities of daily living
10 years
Memory Questionnaire
Time Frame: 10 years
Measures subjective impressions of prospective and retrospective memory
10 years
Multidimensional Fatigue Inventory
Time Frame: 10 years
Measures general, physical, and mental fatigue
10 years
Edinburgh Handedness Scale
Time Frame: 10 years
Standard measure of handedness
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yoon-Hee Cha, MD, University of Minnesota

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

September 2, 2015

First Submitted That Met QC Criteria

September 3, 2015

First Posted (Estimate)

September 4, 2015

Study Record Updates

Last Update Posted (Actual)

March 16, 2023

Last Update Submitted That Met QC Criteria

March 13, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-006-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Anonymized data will be shared once recruitment is sufficient to prevent the inadvertent identification of participants by demographic or clinical characteristics

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mal de Debarquement Syndrome

Clinical Trials on Transcranial Electrical Stimulation

3
Subscribe